抗感染藥物新聞: 全球抗菌及抗濾過性病毒藥物發展監控

尖端抗氧化與抗病毒藥物之全球性最新發展

生技發展瞬息萬變！二十年前抗感染藥物仍被歸類為衍生性產品及抗病毒的特殊療程雛型。二十年後的今日，本領域已 成為媒體爭相報導的議題，例如 - 後天人體免疫缺乏症候群、抗藥性更強大的疾病、及有關流行感冒的療程爭議。

大量的資訊令人眼花撩亂、這也正是為何忙碌的管理人員感激抗感染 藥物新聞(AIN)之處。

AIN提供查詢藥品與企業發展的捷徑，使抗感染領域化繁為簡。每篇36頁以上的專題討論，附上簡明的索引與關鍵資訊。

·  抗感染藥物之新聞報導

研發中心、商品、契約相關規定

抗菌

抗真菌

抗微菌

抗病毒

後天性免疫缺乏徵候群

抗寄生蟲

·  一般發展新聞

研發中心、商品、契約相關規定、無設限代理商

·  會議目錄

一系列即將展開之專題討論、研討會

Current and detailed coverage of the latest antibiotic & antiviral drug developments worldwide

How things change. Twenty years ago the anti-infective sector was characterised by new issues of largely derivative products and antivirals with specific therapeutic action. Over time, though, the area has become one of the most attractive with many issues reaching the popular press - eg AIDS/HIV, greater disease resistance to antibiotics and the controversy surrounding the novel new influenza treatments.

The amount of information around is bewildering which is why busy executives will appreciate Anti - Infective News (AIN).

AIN makes tracking drug & company developments in the anti-infective area easy. Every 36+ page issue is comprehensively indexed and packed with key information on: